Trials / Not Yet Recruiting
Not Yet RecruitingNCT07459686
An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis
Velsipity® Tablets 2 mg Special Investigation (Investigation on Long-Term Use in Patients With Ulcerative Colitis)
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 553 (estimated)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 0 Years
- Healthy volunteers
- Not accepted
Summary
A study to assess the safety and effectiveness of Velsipity Tablets 2 mg during long-term treatment (up to a maximum of 52 weeks) in patients with ulcerative colitis under actual medical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Velsipity | 2 milligrams(mg) tablet as provided in real world practice |
Timeline
- Start date
- 2026-03-31
- Primary completion
- 2029-01-29
- Completion
- 2029-01-29
- First posted
- 2026-03-10
- Last updated
- 2026-03-10
Source: ClinicalTrials.gov record NCT07459686. Inclusion in this directory is not an endorsement.